Key Highlights

  • The company's 2026 operating Earnings range moved up, from USD 600 to 800 million to USD 850 to 950 million, the third lift this year, announced November 5, 2026.
  • Quarterly Revenue reached USD 5.139 billion, compared with USD 2.99 billion a year before, and a USD 250 million risk-adjustment gain provided a boost.
  • The company logged Net Income of USD 167.3 million, or USD 0.49 a diluted share, against a USD 137.5 million loss in the same quarter of 2025.
  • The quarterly medical loss ratio dropped from 88.5% to 84.0%, and SG&A expense as a share of revenue slid from 17.5% to 14.0%.

Operating Outlook Raised for a Third Time

Oscar Health (NYSE:OSCR), a carrier focused on individual and ACA marketplace coverage, published third-quarter 2026 figures on November 5, 2026. Its full-year operating earnings target now spans USD 850 to 950 million, where it previously stood at USD 600 to 800 million. The top-line projection now reads USD 19.0 to 19.3 billion, previously USD 18.7 to 19.0 billion. The projected medical loss ratio now runs 80.5% to 81.5%, while the SG&A ratio is pegged at 15.1% to 15.6%. No verified share reaction was located. The medical loss ratio captures the portion of premiums spent on medical claims, so a smaller number points to better Underwriting profitability. By calculation, the new USD 900 million midpoint exceeds the old USD 700 million midpoint by USD 200 million, roughly 29%.

Membership, Margins and a Risk-Adjustment Lift

Effectuated enrollment reached 2,691,885 at the end of September 2026, up from 2,116,904 a year before, which works out to roughly 27% growth by calculation. A quarterly medical loss ratio of 84.0% beat the 88.5% of the prior year, implying claims absorbed a smaller share of premium. Revenue included a USD 250 million gain from revised risk-adjustment estimates. That transfer mechanism depends on conditions across the broader market, so this kind of item can unwind later. Cash and equivalents stood at USD 4.47 billion, and nine-month Operating Cash Flow hit USD 3.51 billion. Because the earlier-year quarter was a loss, the year-over-year comparison flatters the current period. Revenue grew about 72% from USD 2.99 billion, which reflects enrollment and pricing gains alongside the risk-adjustment item.

Subsidy Rules Cloud the 2027 Picture

The announcement pointed to exposure from expiring enhanced premium tax credits, rules for 2027 payments, and possible financing of a cost-sharing reduction program, but it offered no quantification. Leadership anticipates gaining Market Share and expanding margins during 2027. Policy developments after the November 3 vote could matter, though the reviewed material does not confirm any specific shift. Additional threats include claims cost inflation, lost members if premiums climb, and regulatory transfers that can swing profits between quarters. Growth makes pricing discipline more important, because newcomers may bring claims costs above or below expectations. No share price response was furnished, and none could be checked. Management also gave no figure for how much of that exposure could materialize, which leaves the range of outcomes wide.

Where Things Stand

Chiefly through lower medical and administrative costs, plus a membership-driven lift. Oscar Health (NYSE:OSCR) brought down its medical loss ratio, trimmed administrative spending and gained from a USD 250 million risk-adjustment item, factors that together backed the raised USD 850 to 950 million operating range. The 2027 picture is murkier while Subsidy rules remain unresolved. Upcoming markers include the 2027 open-enrollment window, any federal subsidy decision, and the fourth-quarter report, which should reveal whether Margin improvements persist.